Delta Financial Advisors LLC Abbott Laboratories Transaction History

Delta Financial Advisors LLC

$275 Million
Q3 2024

A detailed history of Delta Financial Advisors LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Delta Financial Advisors LLC holds 15,703 shares of ABT stock, worth $1.85 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares

15,703

Previous 16,092 2.42%

Holding current value

$1.85 Million

Previous $1.67 Million 7.06%

% of portfolio

0.65%

Previous 0.65%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$100.07 - $118.13 $38,927 - $45,952	-389 Reduced 2.42%	15,703 $1.79 Million
Q2 2024 Aug 06, 2024	BUY	$100.73 - $112.44 $3,324 - $3,710	33 Added 0.21%	16,092 $1.67 Million
Q1 2024 May 07, 2024	BUY	$109.52 - $120.96 $3,285 - $3,628	30 Added 0.19%	16,059 $1.83 Million
Q4 2023 Jan 31, 2024	SELL	$90.19 - $110.4 $14,250 - $17,443	-158 Reduced 0.98%	16,029 $1.76 Million
Q3 2023 Nov 03, 2023	BUY	$95.53 - $114.62 $12,514 - $15,015	131 Added 0.82%	16,187 $1.57 Million
Q2 2023 Aug 03, 2023	SELL	$100.78 - $112.29 $7,256 - $8,084	-72 Reduced 0.45%	16,056 $1.75 Million
Q1 2023 May 04, 2023	SELL	$96.86 - $114.01 $37,291 - $43,893	-385 Reduced 2.33%	16,128 $1.63 Million
Q4 2022 Feb 01, 2023	SELL	$95.06 - $111.52 $2,091 - $2,453	-22 Reduced 0.13%	16,513 $1.81 Million
Q3 2022 Oct 27, 2022	BUY	$96.76 - $112.03 $2,515 - $2,912	26 Added 0.16%	16,535 $1.6 Million
Q2 2022 Aug 01, 2022	SELL	$102.07 - $123.37 $7,655 - $9,252	-75 Reduced 0.45%	16,509 $1.79 Million
Q1 2022 May 06, 2022	BUY	$114.02 - $139.04 $2,736 - $3,336	24 Added 0.14%	16,584 $1.96 Million
Q4 2021 Feb 04, 2022	BUY	$115.53 - $141.46 $1,270 - $1,556	11 Added 0.07%	16,560 $2.33 Million
Q3 2021 Oct 26, 2021	SELL	$116.66 - $129.06 $20,998 - $23,230	-180 Reduced 1.08%	16,549 $1.96 Million
Q2 2021 Aug 04, 2021	SELL	$105.79 - $124.53 $16,185 - $19,053	-153 Reduced 0.91%	16,729 $1.94 Million
Q1 2021 Apr 29, 2021	BUY	$108.84 - $128.23 $2,285 - $2,692	21 Added 0.12%	16,882 $2.02 Million
Q4 2020 Jan 28, 2021	SELL	$105.0 - $114.42 $19,320 - $21,053	-184 Reduced 1.08%	16,861 $1.85 Million
Q3 2020 Oct 20, 2020	SELL	$91.64 - $111.29 $22,910 - $27,822	-250 Reduced 1.45%	17,045 $1.86 Million
Q2 2020 Aug 04, 2020	SELL	$76.57 - $98.0 $70,597 - $90,356	-922 Reduced 5.06%	17,295 $1.58 Million
Q1 2020 Apr 27, 2020	SELL	$62.82 - $91.86 $577,190 - $844,009	-9,188 Reduced 33.53%	18,217 $1.44 Million
Q4 2019 Feb 06, 2020	SELL	$78.51 - $87.4 $20,805 - $23,161	-265 Reduced 0.96%	27,405 $2.38 Million
Q3 2019 Oct 30, 2019	SELL	$81.84 - $88.74 $18,905 - $20,498	-231 Reduced 0.83%	27,670 $2.32 Million
Q2 2019 Oct 11, 2019	BUY	$72.88 - $85.0 $2.03 Million - $2.37 Million	27,901 New	27,901 $2.35 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Delta Financial Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Delta Financial Advisors LLC with notifications on news.

Account

Delta Financial Advisors LLC Abbott Laboratories Transaction History